SteelPeak Wealth’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $10.1M | Buy |
+22,594
| New | +$10.1M | 0.39% | 66 |
|
2024
Q4 | – | Sell |
-20,163
| Closed | -$9.38M | – | 540 |
|
2024
Q3 | $9.38M | Buy |
20,163
+19,604
| +3,507% | +$9.12M | 0.41% | 56 |
|
2024
Q2 | $262K | Sell |
559
-20,936
| -97% | -$9.81M | 0.01% | 382 |
|
2024
Q1 | $8.99M | Buy |
21,495
+1,436
| +7% | +$600K | 0.45% | 52 |
|
2023
Q4 | $8.16M | Buy |
20,059
+19,456
| +3,227% | +$7.92M | 0.47% | 58 |
|
2023
Q3 | $210K | Sell |
603
-545
| -47% | -$190K | 0.01% | 363 |
|
2023
Q2 | $404K | Sell |
1,148
-111
| -9% | -$39.1K | 0.02% | 264 |
|
2023
Q1 | $397K | Sell |
1,259
-12,963
| -91% | -$4.08M | 0.03% | 260 |
|
2022
Q4 | $4.11M | Buy |
14,222
+13,422
| +1,678% | +$3.88M | 0.3% | 72 |
|
2022
Q3 | $232K | Buy |
+800
| New | +$232K | 0.02% | 352 |
|
2021
Q3 | – | Sell |
-3,734
| Closed | -$753K | – | 446 |
|
2021
Q2 | $753K | Buy |
3,734
+2,516
| +207% | +$507K | 0.05% | 202 |
|
2021
Q1 | $262K | Sell |
1,218
-8,310
| -87% | -$1.79M | 0.02% | 310 |
|
2020
Q4 | $2.25M | Sell |
9,528
-6,849
| -42% | -$1.62M | 0.2% | 94 |
|
2020
Q3 | $4.46M | Buy |
16,377
+1,126
| +7% | +$306K | 0.48% | 56 |
|
2020
Q2 | $4.43M | Buy |
+15,251
| New | +$4.43M | 0.56% | 52 |
|